Madjus, Mariel B.
HRN: 27-79-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2025
AMPICILLIN 1GM (VIAL)
09/11/2025
09/18/2025
IV
2g
Q6h
THINLY MSAF
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines